Retension Pharmaceuticals, Inc. (RTSN)
NASDAQ: RTSN · Real-Time Price · USD
12.50
+0.29 (2.38%)
Oct 16, 2026, 10:00 AM EDT - Market open
Retension Pharmaceuticals Market Cap
Retension Pharmaceuticals has a market cap or net worth of $104.14 million as of October 16, 2026. It is the 25,144th most valuable company in the world and the 4,088th biggest in the United States.
Market Cap
104.14M
Enterprise Value
90.65M
1-Year Change
n/a
Global Rank
Country Rank
#4,088 United States
Category
ChartMarket Cap Chart
Since the IPO on October 9, 2026, Retension Pharmaceuticals's market cap has increased from $94.58M to $104.14M, an increase of 10.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 104.14M | 2.38% |
| Oct 15, 2026 | 101.73M | 4.90% |
| Oct 14, 2026 | 96.98M | 0.09% |
| Oct 13, 2026 | 96.90M | 2.74% |
| Oct 12, 2026 | 94.31M | -0.28% |
| Oct 9, 2026 | 94.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vivani Medical | 104.18M |
| Coya Therapeutics | 103.21M |
| Cibus | 101.64M |
| Unicycive Therapeutics | 101.11M |
| Tevogen | 100.24M |
| PolyPid | 99.93M |
| ImmuCell | 99.90M |
| Kazia Therapeutics | 99.21M |